Autoantibodies against insulin-like growth factorbinding protein-2 as a serological biomarker in the diagnosis of lung cancer

By                

International Journal of Oncology, Vol. 42, Iss. 1, 2013-01 ,pp. : 93-100

Spandidos Publications

Access to resources Recommend Favorite

Anti-oestrogen Stimulation of ERBB2 Ectodomain Shedding from BT-474 Human Breast Cancer Cells with ERBB2 Gene Amplification

By Warri A.M.   Isola J.J.   Harkonen P.L.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 134-140

Elsevier

Access to resources Recommend Favorite

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer

By Lipton Allan   Goodman Laurie   Leitzel Kim   Cook Jennifer   Sperinde Jeff   Haddad Mojgan   Köstler Wolfgang   Huang Weidong   Weidler Jodi   Ali Suhail   Newton Alicia   Fuchs Eva-Marie   Paquet Agnes   Singer Christian   Horvat Reinhard   Jin Xueguang   Banerjee Joyee   Mukherjee Ali   Tan Yuping   Shi Yining   Chenna Ahmed   Larson Jeff   Lie Yolanda   Sherwood Thomas   Petropoulos Christos   Williams Stephen   Winslow John   Parry Gordon   Bates Michael  

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 43-53

Springer Publishing Company

Access to resources Recommend Favorite

Identification of a new protein biomarker for colorectal cancer diagnosis

By        

Molecular Medicine Reports, Vol. 6, Iss. 2, 2012-01 ,pp. : 444-448

Spandidos Publications

Access to resources Recommend Favorite

Quantitative detection of HER2 protein concentration in breast cancer tissue does not increase the number of patients eligible for adjuvant HER2-targeted therapy

By                

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1475-1482

Spandidos Publications

Access to resources Recommend Favorite